SRCIN1 and cancer: Multiple targets of miR-150 including mucins 4 (MUC4), zinc‐finger E‐box binding homeobox 1 (ZEB1), EGR2, p53, P2X purinoceptor 7 (P2X7), SRC kinase signaling inhibitor 1 (SRCIN1), BRI1‐associated receptor kinase 1 (BAK1), and C-Myb, were also identified in several cancer cells and these targets are involved in the cell proliferation, apoptosis, and metastasis [12, 13, 15–18].